Your browser doesn't support javascript.
loading
Drug target validation in primary human natural killer cells using CRISPR RNP.
Rautela, Jai; Surgenor, Elliot; Huntington, Nicholas D.
Affiliation
  • Rautela J; Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Surgenor E; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
  • Huntington ND; Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
J Leukoc Biol ; 108(4): 1397-1408, 2020 10.
Article in En | MEDLINE | ID: mdl-33463756
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Electroporation / Drug Discovery / CRISPR-Cas Systems Limits: Animals / Humans Language: En Journal: J Leukoc Biol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Electroporation / Drug Discovery / CRISPR-Cas Systems Limits: Animals / Humans Language: En Journal: J Leukoc Biol Year: 2020 Document type: Article Affiliation country: Country of publication: